In Vitro Diagnostics Market (By Product: Instruments, Reagents, Services; By Technology: Immunology, Hematology, Clinical chemistry, Molecular Diagnostics, Coagulation, Microbiology, Others; By Application: Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Drug testing, Others; By End-user: Hospital, Laboratory, Home care, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global In Vitro Diagnostics market size is anticipated to around USD 99.0 billion by 2026, this market is anticipated to grow with 7.1% CAGR during the forecast time period.

Market Dynamics

Increasing occurrence of chronic diseases is foreseen to drive the development of this market. Increase in obesity, unhealthy dietary habits, inactive lifestyle, and high intake of tobacco and alcohol are few of the parameters accountable for high occurrence of diabetes, cancer, cardiovascular diseases, and other illnesses.

As per the National Institute of Health (NIH), in 2017, it was projected that around 23.5 million Americans were living with immune system ailments. The occurrence is relied upon to increment over the the forecast period. In addition, as per the American Cancer Society (ACS), in 2018, about 1.7 million new cancer cases are projected to be accounted for and around 609,640 people are probably going die because of cancer.

Market Insights

Developing utilization of Fluorescence In Situ Hybridization (FISH) and Enzyme Linked Immunosorbent Assay (ELISA) advancements is additionally foreseen to support showcase development amid the estimate time frame. continous R&D to acquaint improved advances are normal with push the market. For example, in November 2017, illumina, Inc., reported the presentation of NextSeq 550Dx instrument, which is relied upon to convey high-throughput Next-Generation Sequencing (NGS) to clinical research centers. The presentation of Xpert measure for tuberculosis testing by Cepheid on its GeneXpert stage is another case of a headway. Such progressions are foreseen to drive the worldwide IVD showcase.

Market Segmentation

Market By Product

  • Instruments
  • Reagents
  • Services

Market By Technology

  • Immunology
  • Hematology
  • Clinical chemistry
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others

Market By Application

  • Infectious disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune diseases
  • Drug testing
  • Others

Market By End-user

  • Hospital
  • Laboratory
  • Home care
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America held the largest market share of 47.44% in 2018. Favourable government regulations, high healthcare spending, and nearness of key market players are the key factors accountable for the regional development.

Also again, Asia Pacific is anticipated to observer the fastest development over the forecast period. It is foreseen to extend at a CAGR of 8.01% over the forecast period. High neglected clinical necessities, enhancing human services framework, and high target populace are foreseen to give development potential to enter producers in the district.

Market Participants

Some of the key players in the in vitro diagnostics market are bioMerieux SA, Dickinson and Company, F. Hoffmann-La Roche Ltd., Hologic, Inc. (Gen-Probe), Siemens Healthineers, Becton, and others. These players are occupied with embracing activities, for example, new item improvement, joint efforts, mergers and procurement to build their share of the overall industry and item portfolio. For example, in September 2018, Ortho Clinical Diagnostics presented VITROS Anti-T. cruzi measure with CE check endorsement in Mexico. What's more, in June 2017, Ortho Clinical Diagnostics propelled VITROS NephroCheck test, a hazard appraisal apparatus for anticipating Acute Kidney Injury, with CE Mark freedom from European Commission.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary